485 related articles for article (PubMed ID: 10213339)
1. Sudden cardiac death: who needs an implantable cardioverter-defibrillator and who needs antiarrhythmic drugs?
Ferrari R; Cinca J; Marber M
Eur Heart J; 1999 Mar; 20(6):397-8. PubMed ID: 10213339
[No Abstract] [Full Text] [Related]
2. [Pharmacologic therapy of ventricular tachyarrhythmias: value of class III anti-arrhythmia drugs].
Haverkamp W; Borggrefe M; Block M; Böcker D; Breithardt G
Z Kardiol; 1996; 85 Suppl 6():97-106. PubMed ID: 9064989
[TBL] [Abstract][Full Text] [Related]
3. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
Lau EW; Griffith MJ; Pathmanathan RK; Ng GA; Clune MM; Cooper J; Marshall HJ; Forsey PR; Stafford PJ; Gray RG; Skehan JD; Garratt CJ
Europace; 2004 Jul; 6(4):257-66. PubMed ID: 15172648
[TBL] [Abstract][Full Text] [Related]
4. The role of prophylactic implantable cardioverter defibrillators to prevent sudden cardiac death.
Talajic M; Mitchell LB; Hadjis T
Can J Cardiol; 2000 Jun; 16 Suppl C():26C-8C. PubMed ID: 10887275
[No Abstract] [Full Text] [Related]
5. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
[TBL] [Abstract][Full Text] [Related]
6. [Congestive heart failure and arrhythmia].
Kasanuki H
Nihon Rinsho; 1993 May; 51(5):1354-61. PubMed ID: 8101240
[TBL] [Abstract][Full Text] [Related]
7. Is primary antiarrhythmic drug therapy for ventricular arrhythmias obsolete?
Cooley R; Akhtar M; Sra J
Curr Cardiol Rep; 1999 Nov; 1(4):268-73. PubMed ID: 10980853
[TBL] [Abstract][Full Text] [Related]
8. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
[TBL] [Abstract][Full Text] [Related]
9. Do we need a randomized trial of defibrillator therapy in every subset of patients with increased risk of sudden death?
Exner DV; Klein GJ
J Cardiovasc Electrophysiol; 2003 Jun; 14(6):574-7. PubMed ID: 12875415
[No Abstract] [Full Text] [Related]
10. Antiarrhythmic drugs or implantable cardioverter defibrillators in heart failure: the "poor heart".
Böcker D; Breithardt G
Am J Cardiol; 1999 Mar; 83(5B):83D-87D. PubMed ID: 10089846
[TBL] [Abstract][Full Text] [Related]
11. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
[TBL] [Abstract][Full Text] [Related]
12. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
Ho AT; Pai SM; Timothy P; Pai RG
Pacing Clin Electrophysiol; 2005 Jul; 28(7):647-53. PubMed ID: 16008799
[TBL] [Abstract][Full Text] [Related]
13. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
Kuck KH
Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
[No Abstract] [Full Text] [Related]
14. Role of antiarrhythmic drugs: frequent implantable cardioverter-defibrillator shocks, risk of proarrhythmia, and new drug therapy.
Droogan C; Patel C; Yan GX; Kowey PR
Heart Fail Clin; 2011 Apr; 7(2):195-205, viii. PubMed ID: 21439498
[TBL] [Abstract][Full Text] [Related]
15. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy.
Patel C; Yan GX; Kocovic D; Kowey PR
Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):705-11; discussion 712. PubMed ID: 20009081
[No Abstract] [Full Text] [Related]
16. [How do you want to die? The therapeutic options in ventricular tachyarrhythmia at the end of the anti-arrhythmia drug era].
Seipel L
Z Kardiol; 1995 Oct; 84(10):787-90. PubMed ID: 7502564
[No Abstract] [Full Text] [Related]
17. [Implantable cardioverter-defibrillator: prevention of sudden cardiac death and impact on survival in patients with malignant ventricular arrhythmias].
Occhetta E; Magnani A; Francalacci G; Perucca A; Sarasso G; Piccinino C; Trevi G
Cardiologia; 1995 Jun; 40(6):419-25. PubMed ID: 8640855
[No Abstract] [Full Text] [Related]
18. Ventricular tachycardia and sudden cardiac death.
Reddy PC; Tandon N; Stafford PR
J La State Med Soc; 1999 May; 151(5):281-7. PubMed ID: 10363484
[TBL] [Abstract][Full Text] [Related]
19. Drugs for ventricular arrhythmias in the era of the implantable cardioverter defibrillator.
Peters NS
Eur Heart J; 1999 Mar; 20(5):321-3. PubMed ID: 10206376
[No Abstract] [Full Text] [Related]
20. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
N Engl J Med; 1997 Nov; 337(22):1576-83. PubMed ID: 9411221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
